BDBM161086 US9682976, 39

SMILES Cn1nnn(-c2cc(Nc3ncc(F)c(N[C@@H]4CC5CCCN5C(C)(C)C4)n3)ccc2OC2COC2)c1=O

InChI Key InChIKey=HIJUKDHGAOXGAM-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 161086   

TargetInterleukin-2(Human)
Rigel Pharmaceuticals

US Patent
LigandPNGBDBM161086(US9682976, 39)
Affinity DataEC50: <500nMAssay Description:Primary T cell stimulation and IL2 ELISA: Human primary T cells (100,000 cells per well) were pre-incubated with or without test compound in Yssel...More data for this Ligand-Target Pair
In DepthDetails
US Patent